Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
Search insider filingsAll Congress filings
MORE TOOLS
WatchlistGold IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeSearch insider filingsAll Congress filings
More research tools
ExploreGold IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
Back to Home
D

DNA

NYSE

Ginkgo Bioworks Holdings, Inc.

Latest disclosureOctober 7, 2026
Insider score Why 0?
0/ 100
Qualifying buys · 30d
$0

0 purchases · 15 sales

Price by TradingViewDelayed quote from TradingView, for viewing only. It does not power Whale Atlas scores or alerts. If the quote does not load, open the TradingView link.

Insider transactions 65

Limited filing history
All65Buying0Selling15Other50
Filters

Last 30 daysNo qualifying insider buying. Sales: $71.45K by 2 insiders.

15 of 65 trades · April 7, 2026 – October 5, 2026Incomplete history: this shows the filings imported so far, not every filing ever made. Dates are trade dates. Filters affect this table only.

Showing the first 6 of 15 trades on this page.

Sale disclosed

Steven P. Coen

See remarks

Class A Common Stock

Reported value
$36.05K
Reported price
$15.00 / share
Traded October 5, 2026Filed October 7, 2026SEC filing
Sale disclosed

Christian O. Henry

Director

Class A Common Stock

Reported value
$35.41K
Reported price
$7.081 / share
Traded September 15, 2026Filed September 16, 2026SEC filing
Sale disclosed

Steven P. Coen

See remarks

Class A Common Stock

Reported value
$2.3K
Reported price
$6.977 / share
Traded August 24, 2026Filed August 25, 2026SEC filing
Sale disclosed

Steven P. Coen

See remarks

Class A Common Stock

Reported value
$5.94K
Reported price
$7.903 / share
Traded July 17, 2026Filed July 20, 2026SEC filing
Sale disclosed

Steven P. Coen

See remarks

Class A Common Stock

Reported value
$2.56K
Reported price
$8.334 / share
Traded May 22, 2026Filed May 26, 2026SEC filing
Sale disclosed

Steven P. Coen

See remarks

Class A Common Stock

Reported value
$2.58K
Reported price
$7.952 / share
Traded April 17, 2026Filed April 20, 2026SEC filing
Sale disclosed

Steven P. Coen

See remarks

Class A Common Stock

Reported value
$212.76K
Reported price
$6.414 / share
Traded April 13, 2026Filed April 14, 2026SEC filing
Sale disclosed

Barry Canton

10% owner

Class A Common Stock

Reported value
$802.49K
Reported price
$6.434 / share
Traded April 10, 2026Filed April 13, 2026SEC filing
Sale disclosed

Reshma P. Shetty

See remarks

Class A Common Stock

Reported value
$802.49K
Reported price
$6.434 / share
Traded April 10, 2026Filed April 13, 2026SEC filing
Sale disclosed

Reshma P. Shetty

See remarks

Class A Common Stock

Reported value
$91.16K
Reported price
$6.93 / share
Traded April 8, 2026Filed April 10, 2026SEC filing
Sale disclosed

Reshma P. Shetty

See remarks

Class A Common Stock

Reported value
$83.9K
Reported price
$6.397 / share
Traded April 9, 2026Filed April 10, 2026SEC filing
Sale disclosed

Barry Canton

10% owner

Class A Common Stock

Reported value
$91.16K
Reported price
$6.93 / share
Traded April 8, 2026Filed April 10, 2026SEC filing
Sale disclosed

Barry Canton

10% owner

Class A Common Stock

Reported value
$83.9K
Reported price
$6.397 / share
Traded April 9, 2026Filed April 10, 2026SEC filing
Sale disclosed

Jason R. Kelly

See remarks

Class A Common Stock

Reported value
$672.31K
Reported price
$6.93 / share
Traded April 8, 2026Filed April 10, 2026SEC filing
Sale disclosed

Jason R. Kelly

See remarks

Class A Common Stock

Reported value
$702.18K
Reported price
$6.397 / share
Traded April 9, 2026Filed April 10, 2026SEC filing
Reporting insiderSecurity / transactionAmount / priceValueTraded / disclosedSource
See remarksClass A Common StockSale10b5-12,403$15.00 / share$36.05KOct 5Filed Oct 7 · 2d laterSEC filing
DirectorClass A Common StockSale5,000$7.08 / share$35.41KSep 15Filed Sep 16 · 1d laterSEC filing
See remarksClass A Common StockSale330$6.98 / share$2.3KAug 24Filed Aug 25 · 1d laterSEC filing
See remarksClass A Common StockSale752$7.90 / share$5.94KJul 17Filed Jul 20 · 3d laterSEC filing
See remarksClass A Common StockSale307$8.33 / share$2.56KMay 22Filed May 26 · 4d laterSEC filing
See remarksClass A Common StockSale324$7.95 / share$2.58KApr 17Filed Apr 20 · 3d laterSEC filing
See remarksClass A Common StockSale33,171$6.41 / share$212.76KApr 13Filed Apr 14 · 1d laterSEC filing
10% ownerClass A Common StockSale124,727$6.43 / share$802.49KApr 10Filed Apr 13 · 3d laterSEC filing
See remarksClass A Common StockSale124,727$6.43 / share$802.49KApr 10Filed Apr 13 · 3d laterSEC filing
See remarksClass A Common StockSale13,155$6.93 / share$91.16KApr 8Filed Apr 10 · 2d laterSEC filing
See remarksClass A Common StockSale13,116$6.40 / share$83.9KApr 9Filed Apr 10 · 1d laterSEC filing
10% ownerClass A Common StockSale13,155$6.93 / share$91.16KApr 8Filed Apr 10 · 2d laterSEC filing
10% ownerClass A Common StockSale13,116$6.40 / share$83.9KApr 9Filed Apr 10 · 1d laterSEC filing
See remarksClass A Common StockSale97,015$6.93 / share$672.31KApr 8Filed Apr 10 · 2d laterSEC filing
See remarksClass A Common StockSale109,767$6.40 / share$702.18KApr 9Filed Apr 10 · 1d laterSEC filing

Congress transactions 0

All Congress filings
No disclosed congressional trades for DNA in the imported filings.

This reflects the filings imported so far, not a complete trading history.

Explore furtherTechnical lab Company financials Test a strategy Compare company

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage
Source
SEC EDGAR · Form 4
Issuer CIK
0001830214
Latest public acceptance
Oct 7, 2026, 09:00 PM UTC
Score calculated
Oct 7, 2026, 09:02 PM UTC
Parser
form4-parser-1.5
Classifier
form4-classifier-1.1
Scoring methodology
insider-experimental-1.1
Availability
Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.